SCHEMBL803200

SCHEMBL803200

Cc1ccc2c(c1C)COc1c-2ccc(C)c1C

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.62
ESR2 Q92731 2/20 0.62
KCNJ1 P48048 7/20 0.39
TDP2 O95551 1/20 0.38
NSD2 O96028 1/20 0.38
HSP90AA1 P07900 1/20 0.38
PAX8 Q06710 1/20 0.38
PGR P06401 6/20 0.36
KCNH2 Q12809 6/20 0.35
ACHE P22303 1/20 0.34
SSTR1 P30872 1/20 0.34
SLC6A4 P31645 1/20 0.34
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
POLB P06746 1/20 0.31
NR3C1 P04150 1/20 0.30
AR P10275 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21451571 0.85 ESR1 (0.51) ESR1ESR2KCNJ1PGRKCNH2
SCHEMBL22650585 0.85 ESR1 (0.51) ESR1ESR2KCNJ1TDP2NSD2
SCHEMBL802785 0.85 ESR1 (0.51) ESR1ESR2KCNJ1TDP2NSD2
SCHEMBL803047 0.84 ESR1 (0.50) ESR1ESR2KCNJ1TDP2NSD2
SCHEMBL6830103 0.77 ESR1 (1.00) ESR1ESR2KCNJ1KCNH2ACHE
SCHEMBL15036782 0.76 KCNJ1 (0.64) KCNJ1TDP2NSD2HSP90AA1PAX8
SCHEMBL14883992 0.76 PSMB5 (0.52) ESR1ESR2KCNJ1TDP2NSD2
SCHEMBL22644204 0.76 ESR1 (0.43) ESR1ESR2KCNJ1KCNH2
SCHEMBL23289004 0.76 ESR1 (0.42) ESR1ESR2KCNJ1KCNH2
SCHEMBL23284915 0.76 ESR1 (0.44) ESR1ESR2TDP2NSD2HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12035546-B2 Method for producing an electronic component which includes a self-assembled monolayer MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
WO-2023174896-A1 ELECTRONIC SWITCHING DEVICE MERCK PATENT GMBH (DE) 2023-09-21 WO disclosed
EP-4102571-A1 ELECTRONIC ELEMENT COMPRISING A PLURALITY OF CELLS ARRANGED IN A THREE DIMENSIONAL ARRAY OF CELLS AND METHOD FOR PRODUCING SUCH AN ELECTRONIC DEVICE Merck Patent GmbH (DE) 2022-12-14 EP disclosed
US-9650573-B2 Liquid crystalline medium and liquid crystal device MERCK PATENT GMBH (DE) 2017-05-16 US disclosed
US-20170029702-A1 LIQUID CRYSTAL MATERIAL MERCK PATENT GMBH (DE) 2017-02-02 US disclosed
US-9507185-B2 Switch element comprising a liquid crystalline medium MERCK PATENT GMBH (DE) 2016-11-29 US disclosed
US-20160108318-A1 LIQUID CRYSTALLINE MEDIUM AND LIQUID CRYSTAL DEVICE MERCK PATENT GMBH (DE) 2016-04-21 US disclosed
US-20160060530-A1 DEVICE CONTAINING A LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2016-03-03 US disclosed
US-9096795-B2 Liquid crystal display MERCK PATENT GMBH (DE) 2015-08-04 US disclosed
US-8993074-B2 Liquid crystal display device and method of manufacturing the same SONY CORPORATION (JP) 2015-03-31 US disclosed
US-20140293174-A1 SWITCH ELEMENT COMPRISING A LIQUID CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2014-10-02 US disclosed
US-20140111752-A1 LIQUID CRYSTAL DISPLAY DEVICE AND METHOD OF MANUFACTURING THE SAME SONY CORPORATION (JP) 2014-04-24 US disclosed
US-20120069289-A1 LIQUID CRYSTAL DISPLAY MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120069289-A1 LIQUID CRYSTAL DISPLAY LPXN, VCL, ACP3 ESR1 1013/4885ESR2 2665/4885KCNJ1 4730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.